Literature DB >> 6141505

Analgesic effects of mu-, delta- and kappa-opiate agonists and, in particular, dynorphin at the spinal level.

R Przewłocki, L Stala, M Greczek, G T Shearman, B Przewłocka, A Herz.   

Abstract

To investigate the role of multiple opiate receptors in spinal mechanisms of antinociception the activity of various opiate receptor agonists was determined against different nociceptive stimuli in the mouse and rat. Intrathecal administration of the putative kappa-receptor agonists dynorphin A (DYN), bremazocine, and ethylketocyclazocine, as well as the delta-agonist D-Ala2,D-Leu5-enkephalin and the mu-agonists, Tyr-D-Ala-Gly-MePhe-NH-(CH2)2OH and morphine resulted in a dose-dependent antinociceptive effect. The order of potencies was similar for visceral and thermal pain. Inhibition of writhing in mice was much more strongly antagonized by MR 2266 than by naloxone, and des-Tyr1-DYN1-13 was 50 times less potent than DYN in this test suggesting that DYN acts through the kappa-receptor. It is concluded that mu-, delta- and kappa-opiate receptors are involved in spinally mediated antinociception related to kinds of noxious stimuli.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6141505     DOI: 10.1016/0024-3205(83)90586-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

Review 1.  Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.

Authors:  V K Shukla; S Lemaire
Journal:  J Psychiatry Neurosci       Date:  1992-09       Impact factor: 6.186

2.  Estrogens as arbiters of sex-specific and reproductive cycle-dependent opioid analgesic mechanisms.

Authors:  Alan R Gintzler; Emiliya M Storman; Nai-Jiang Liu
Journal:  Vitam Horm       Date:  2019-07-02       Impact factor: 3.421

Review 3.  Spinal opioid analgesia. A critical update.

Authors:  L L Gustafsson; Z Wiesenfeld-Hallin
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

4.  Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.

Authors:  C G Parsons; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

5.  Antagonists of the kappa-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation.

Authors:  I Obara; J Mika; M K-H Schafer; B Przewlocka
Journal:  Br J Pharmacol       Date:  2003-09-01       Impact factor: 8.739

Review 6.  The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective.

Authors:  Sonia Podvin; Tony Yaksh; Vivian Hook
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

7.  Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.

Authors:  Alice A Larson; Myra G Nunez; Casey L Kissel; Katalin J Kovács
Journal:  Eur J Neurosci       Date:  2015-10-09       Impact factor: 3.386

8.  Effects of acute agonist treatment on subcellular distribution of kappa opioid receptor in rat spinal cord.

Authors:  Yulin Wang; Wei Xu; Peng Huang; Charles Chavkin; Elisabeth J Van Bockstaele; Lee-Yuan Liu-Chen
Journal:  J Neurosci Res       Date:  2009-05-15       Impact factor: 4.164

9.  Modulation of somatocardiac sympathetic reflexes mediated by opioid receptors at the spinal and brainstem level.

Authors:  A Sato; Y Sato; R F Schmidt
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

10.  A prolonged nitric oxide-dependent, opioid-mediated antinociceptive effect of hyperbaric oxygen in mice.

Authors:  Lisa M Zelinski; Yusuke Ohgami; Eunhee Chung; Donald Y Shirachi; Raymond M Quock
Journal:  J Pain       Date:  2008-10-31       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.